Niki BioSolutions Files Corporate Presentation (8-K)

What Happened Niki BioSolutions, Inc. (NIKI) filed a Current Report on Form 8‑K dated September 14, 2026 to disclose and furnish its corporate PowerPoint presentation as Exhibit 99.1. The company clarified that neither the 8‑K nor the attached presentation constitutes an offer to sell or a solicitation to buy its securities in any jurisdiction where such an offer would be unlawful.

Key Details

• Filing date: September 14, 2026 (Form 8‑K, Accession No. 0001213900-26-099695).
• Exhibit furnished: 99.1 — Corporate PowerPoint presentation.
• Legal note: The filing explicitly states it is not an offer to sell or solicit the purchase of securities.
• Technical exhibit: Cover Page Interactive Data File provided in Inline XBRL (Exhibit 104).

Why It Matters This 8‑K is primarily an informational disclosure to investors that the company has updated or shared its corporate presentation. There are no financial results, management changes, or transaction announcements in this filing, so it does not directly affect earnings, revenue, or corporate control. Investors may review the furnished presentation for updated strategy, pipeline, or corporate messaging, but should treat it as informational and not as a securities offering.